IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$9.91
Tradestie Score
57
Market Cap
$1.09B
Revenue Growth
-0.6%
Analyst Upside
+89.5%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.91
|
$1.42B | - | 67 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.61
|
$1.35B | - | 61 | Compare |
|
MPLT
MPLT
|
$28.64
|
$1.34B | - | 54 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$38.88
|
$1.32B | - | 65 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.20
|
$1.29B | 98.6 | 67 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$31.11
|
$1.29B | - | 67 | Compare |
|
ARDX
Ardelyx, Inc.
|
$6.18
|
$1.29B | - | 59 | Compare |
|
ZYME
Zymeworks Inc.
|
$23.88
|
$1.28B | - | 63 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.04
|
$1.27B | - | 60 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$39.87
|
$1.26B | - | 55 | Compare |
More IMTX Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry